The Food and Drug Administration (FDA) has published a draft guidance document on the registration and listing of cosmetic product facilities and products, as part of the implementation process for the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). This action marks a significant shift in FDA’s oversight of the cosmetics industry, introducing new standards that manufacturers, packers, and distributors must now adhere to.
The MoCRA enacted considerable changes to FDA regulations pertaining to cosmetics, reflecting a commitment to modernize and improve cosmetics regulation. Notably, this legislation mandates the registration of cosmetic product facilities and products. This draft guidance document provides guidance for the industry for achieving compliance with these requirements.
For legal professionals working in major corporations and law firms, particularly those with clients or employers in the cosmetics industry, it is pertinent to thoroughly understand the implications of these modifications. This shift necessitates comprehensive understanding of the specific requirements and standards in the MoCRA to ensure thorough compliance.
Furthermore, the end-of-year deadlines presented in the draft guidance should be carefully taken into account by these entities. FDA’s draft guidance document on the registration and listing of cosmetic product facilities and products serves to explicate these new regulatory changes and provide guidance to industry stakeholders on the necessary steps for compliance.
Undoubtedly, this draft guidance provides a valuable resource for navigating the new landscape presented by the MoCRA. In conclusion, legal professionals invested in the cosmetics industry would benefit significantly from a detailed examination of this useful document in anticipation of the upcoming changes and deadlines.